QT
COGT icon

Quantbot Technologies’s Cogent Biosciences COGT Stock Holding History

Quantbot Technologies’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.4K Buy
1,380
+1,338
+3,186% +$46.8K ﹤0.01% 1621
2026
Q1 		$1.62K Sell
42
-5,373
-99% -$198K ﹤0.01% 1616
2025
Q4 		$192K Sell
5,415
-5,752
-52% -$162K 0.01% 1250
2025
Q3 		$160K Sell
11,167
-4,350
-28% -$51.5K ﹤0.01% 1358
2025
Q2 		$111K Sell
15,517
-5,533
-26% -$30.7K ﹤0.01% 1384
2025
Q1 		$126K Sell
21,050
-603
-3% -$4.73K ﹤0.01% 1208
2024
Q4 		$169K Buy
+21,653
New +$216K 0.01% 1086
2023
Q1 		– Sell
-2,100
Closed -$24.3K – 1619
2022
Q4 		$24.3K Sell
2,100
-19,800
-90% -$245K ﹤0.01% 1417
2022
Q3 		$326K Buy
21,900
+15,900
+265% +$218K 0.02% 725
2022
Q2 		$54K Buy
6,000
+3,600
+150% +$24.6K 0.01% 1289
2022
Q1 		$17K Sell
2,400
-400
-14% -$2.79K ﹤0.01% 1388
2021
Q4 		$24K Buy
+2,800
New +$24.3K ﹤0.01% 1192

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Quantbot Technologies's COGT Position: Q2 2026 in Review

Quantbot Technologies increased its Cogent Biosciences (COGT) stake by 3,186% in Q2 2026, buying an estimated $46.8K and bringing the position to 1,380 shares worth $53.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1621.

Quantbot Technologies first reported a position in COGT in Q4 2021 and has held it in 12 quarters since. The position peaked at $326K in Q3 2022. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Quantbot Technologies held 1,380 shares of Cogent Biosciences worth $53.4K as of Q2 2026.
  • Quantbot Technologies bought 1,338 Cogent Biosciences shares in Q2 2026, an estimated $46.8K.
  • Cogent Biosciences made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1621 holding.
  • Quantbot Technologies first reported a position in Cogent Biosciences in Q4 2021 and has held it in 12 quarters since.
  • Quantbot Technologies's Cogent Biosciences position peaked at $326K in Q3 2022.
  • 324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.